Home » Topics » BioWorld Science

BioWorld Science
RSS

Clenbuterol improves muscle function in patients with late-onset Pompe disease

Feb. 13, 2018

WntResearch revises design of planned phase II study of Foxy-5

Feb. 13, 2018

Avid Bioservices and Oncologie enter agreement for PS-targeting program

Feb. 13, 2018

Kadmon reports phase II data on KD-025 in IPF

Feb. 13, 2018

Audentes Therapeutics begins dosing in phase I/II VALENS study

Feb. 13, 2018

Opiant Pharmaceuticals announces plans for intranasal nalmefene

Feb. 13, 2018

FDA approves Symdeko to treat underlying cause of cystic fibrosis

Feb. 13, 2018

Sirenas and BMS enter multitarget research collaboration

Feb. 13, 2018

Foundation Fighting Blindness to support development of ProQR's candidate for Usher syndrome 2A

Feb. 13, 2018

First-in-human results presented for SBC-103 in children with MPS IIIB

Feb. 13, 2018